Pedro P. Cunha

Team icon

PostDoc Researcher

Immune Cell Reprogramming

Publications

Show less

Information about journal articles, updated at 14-05-2024, from platform CIÊNCIAVITAE.

The two enantiomers of 2-hydroxyglutarate differentially regulate cytotoxic T cell function

Iosifina P. Foskolou; Pedro P. Cunha; Elena Sánchez-López; Eleanor A. Minogue; Benoît P. Nicolet; Aurélie Guislain; Christian Jorgensen; et al, Cell Reports. 2023. http://dx.doi.org/10.1016/j.celrep.2023.113013 . 10.1016/j.celrep.2023.113013 . Cell Reports

Glutarate regulates T cell metabolism and anti-tumour immunity

Eleanor Minogue; Pedro P. Cunha; Brennan Wadsworth; Guinevere L. Grice; shiv kumar Sah-Teli; Rob Hughes; David Bargiela; et al, Nature Metabolism. 2023. http://dx.doi.org/10.1038/s42255-023-00855-2 . 10.1038/s42255-023-00855-2 . Nature Metabolism

Lactate exposure shapes the metabolic and transcriptomic profile of CD8+ T cells

Laura Barbieri; Pedro Veliça; Paulo A. Gameiro; Pedro P. Cunha; Iosifina P. Foskolou; Eric Rullman; David Bargiela; Randall S. Johnson; Helene Rundqvist, Frontiers in Immunology. 14. 2023. http://dx.doi.org/10.3389/fimmu.2023.1101433 . 10.3389/fimmu.2023.1101433 . Frontiers in Immunology

Oxygen levels at the time of activation determine T cell persistence and immunotherapeutic efficacy

Pedro P Cunha; Eleanor Minogue; Lena CM Krause; Rita M Hess; David Bargiela; Brennan J Wadsworth; Laura Barbieri; et al, eLife. 2023. https://doi.org/10.7554/eLife.84280 . 10.7554/eLife.84280 . eLife

Vitamin B6 Metabolism Determines T Cell Anti-Tumor Responses

David Bargiela; Pedro P. Cunha; Pedro Veliça; Iosifina P. Foskolou; Laura Barbieri; Helene Rundqvist; Randall S. Johnson, Frontiers in Immunology. 13. 2022. http://dx.doi.org/10.3389/fimmu.2022.837669 . 10.3389/fimmu.2022.837669 . Frontiers in Immunology

Infiltration of tumors is regulated by T cell-intrinsic nitric oxide synthesis

Pedro P. Cunha; David Bargiela; Eleanor Minogue; Lena C.M. Krause; Laura Barbieri; Carolin Brombach; Milos Gojkovic; et al, Cancer Immunology Research. 2022. https://doi.org/10.1158/2326-6066.CIR-22-0387 . 10.1158/2326-6066.CIR-22-0387 . Cancer Immunology Research

Modified hypoxia-inducible factor expression in CD8<sup>þ</sup> T cells increases antitumor efficacy

Veliça, P.; Cunha, P.P.; Vojnovic, N.; Foskolou, I.P.; Bargiela, D.; Gojkovic, M.; Rundqvist, H.; Johnson, R.S., Cancer Immunology Research. 401 - 414. 4. 9. 2021. http://www.scopus.com/inward/record.url?eid=2-s2.0-85104428121&partnerID=MN8TOARS . 10.1158/2326-6066.CIR-20-0561 . Cancer Immunology Research

Oxygen regulation of TET enzymes

Matuleviciute, R.; Cunha, P.P.; Johnson, R.S.; Foskolou, I.P., FEBS Journal. 2021. http://www.scopus.com/inward/record.url?eid=2-s2.0-85099991597&partnerID=MN8TOARS . 10.1111/febs.15695 . FEBS Journal

Differentiation of glioblastoma stem cells promoted by miR-128 or miR-302a overexpression enhances senescence-associated cytotoxicity of axitinib

Cardoso, A.M.; Morais, C.M.; Pena, F.; Marante, T.; Cunha, P.P.; Jurado, A.S.; Pedroso de Lima, M.C., Human Molecular Genetics. 160 - 171. 3-4. 30. 2021. http://www.scopus.com/inward/record.url?eid=2-s2.0-85106069155&partnerID=MN8TOARS . 10.1093/hmg/ddab011 . Human Molecular Genetics

Oxygen-Mediated Suppression of CD8+ T Cell Proliferation by Macrophages: Role of Pharmacological Inhibitors of HIF Degradation

Gojkovic, M.; Cunha, P.P.; Darmasaputra, G.S.; Barbieri, L.; Rundqvist, H.; Veliça, P.; Johnson, R.S., Frontiers in Immunology. 12. 2021. http://www.scopus.com/inward/record.url?eid=2-s2.0-85107036662&partnerID=MN8TOARS . 10.3389/fimmu.2021.633586 . Frontiers in Immunology

miRNA-31 Improves Cognition and Abolishes Amyloid-ß Pathology by Targeting APP and BACE1 in an Animal Model of Alzheimer’s Disease

Cunha, Pedro, Molecular Therapy - Nucleic Acids. 2020. http://dx.doi.org/10.1016/j.omtn.2020.01.010 . 10.1016/j.omtn.2020.01.010 . Molecular Therapy - Nucleic Acids

The S enantiomer of 2-hydroxyglutarate increases central memory CD8 populations and improves CAR-T therapy outcome

Iosifina P. Foskolou; Laura Barbieri; Aude Vernet; David Bargiela; Pedro P. Cunha; Pedro Velica; Eunyeong Suh; et al, Blood Advances. 2020. https://doi.org/10.1182/bloodadvances.2020002309 . 10.1182/bloodadvances.2020002309 . Blood Advances

Glucosylceramide synthase silencing combined with the receptor tyrosine kinase inhibitor axitinib as a new multimodal strategy for glioblastoma

Catarina M Morais; Pedro P Cunha; Tânia Melo; Ana M Cardoso; Pedro Domingues; M Rosário Domingues; Maria C Pedroso de Lima; Amália S Jurado, Human Molecular Genetics. 2019. https://doi.org/10.1093/hmg/ddz152 . 10.1093/hmg/ddz152 . Human Molecular Genetics

Acylation of the S4<inf>13</inf>-PV cell-penetrating peptide as a means of enhancing its capacity to mediate nucleic acid delivery: Relevance of peptide/lipid interactions

Morais, C.M.; Cardoso, A.M.; Cunha, P.P.; Aguiar, L.; Vale, N.; Lage, E.; Pinheiro, M.; et al, Biochimica et Biophysica Acta - Biomembranes. 2619 - 2634. 12. 1860. 2018. http://www.scopus.com/inward/record.url?eid=2-s2.0-85054439165&partnerID=MN8TOARS . 10.1016/j.bbamem.2018.10.002 . Biochimica et Biophysica Acta - Biomembranes

High-throughput screening uncovers miRNAs enhancing glioblastoma cell susceptibility to tyrosine kinase inhibitors

Pedro P Cunha; Pedro M Costa; Catarina M Morais; Inês R Lopes; Ana M Cardoso; Ana L Cardoso; Miguel Mano; Amália S Jurado; Maria C Pedroso de Lima, Human Molecular Genetics. 4375 - 4387. 22. 26. 2017. https://doi.org/10.1093/hmg/ddx323 . 10.1093/hmg/ddx323 . Human Molecular Genetics

MiRNA-21 silencing mediated by tumor-targeted nanoparticles combined with sunitinib: A new multimodal gene therapy approach for glioblastoma

Cunha, Pedro, Journal of Controlled Release . 2015. http://www.sciencedirect.com/science/article/pii/S0168365915002205 . http://dx.doi.org/10.1016/j.jconrel.2015.04.002 . Journal of Controlled Release

All projects

Show less

Information of exclusive responsibility of the researcher 14-05-2024 , from platform CIÊNCIAVITAE.

2023/02/14 - 2025/12/31

CInTech: Technological Hub for Innovation, Translation and Industrialization of Complex Injectable Drugs

C644865576-00000005

Post-doc

Universidade de Coimbra Centro de Inovação em Biomedicina e Biotecnologia

2022/04 - 2022/12

Hypoxia, HIF function and immunotherapy

CAN2018/808

Invited Scientist Fellow

Karolinska Institutet

Funders: Cancerfonden

2017/09 - 2022/12

Oxygen and the immune response

214283/Z/18/Z

Research Fellow

University of Cambridge Queens' College

Funders: Wellcome Foundation Ltd

2017/01 - 2017/08

Differentiation therapy toward glioblastoma stem-like cells

POCI-01-0145- FEDER-016390

Research Fellow

Universidade de Coimbra Centro de Inovação em Biomedicina e Biotecnologia

Funders: Autoridade de Gestão do Programa Operacional Competitividade e Internacionalização

2017 - 2022

The role of hypoxia in T cell function and Imunotherapy

SFRH/BD/115612/2016

PhD Student Fellow

University of Cambridge Queens' College

Funders: Fundação para a Ciência e a Tecnologia

We use cookies to improve your visit to our website.